본문 바로가기

추천 검색어

실시간 인기 검색어

학술논문

PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy

이용수 20

영문명
발행기관
대한방사선종양학회
저자명
Ick Joon Cho Jae-Uk Jeong Taek-Keun Nam Young-Eun Joo Sung-Bum Cho Yong-Hyub Kim Ju-Young Song Mee Sun Yoon Sung-Ja Ahn Woong-Ki Chung
간행물 정보
『대한방사선종양학회지』제40권 제1호, 20~28쪽, 전체 9쪽
주제분류
의약학 > 종양학
파일형태
PDF
발행일자
2022.03.30
4,000

구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

1:1 문의
논문 표지

국문 초록

영문 초록

Purpose: This study aimed to determine the correlation between protein induced by vitamin K absence or antagonist-II (PIVKA-II) and stereotactic body radiotherapy (SBRT) in patients with hepatocellular carcinoma (HCC). Materials and Methods: Sixty-one patients received SBRT between 2015 and 2020 with a median dose of 48 Gy (range, 39 to 60 Gy) with a median of 4 fractions. Changes in tumor markers before and after SBRT were analyzed. Results: The median follow-up period was 31 months (range, 12 to 64 months). The estimated 2-year in-field failure-free survival, progression-free survival (PFS), and overall survival rates were 82.0%, 39.3%, and 96.7%, respectively. Patients with decreased PIVKA-II levels through SBRT had significantly few in-field failures (p = 0.005). Patients with PIVKA-II levels of ≤25 mAU/mL after SBRT had significantly long PFS (p = 0.004). Conclusion: PIVKA-II could be a useful surrogate marker for response or survival outcomes in patients with localized HCC receiving SBRT.

목차

Introduction
Materials and Methods
Results
Conflict of Interest
Acknowledgements
References

키워드

해당간행물 수록 논문

참고문헌

교보eBook 첫 방문을 환영 합니다!

신규가입 혜택 지급이 완료 되었습니다.

바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!

교보e캐시 1,000원
TOP
인용하기
APA

Ick Joon Cho,Jae-Uk Jeong,Taek-Keun Nam,Young-Eun Joo,Sung-Bum Cho,Yong-Hyub Kim,Ju-Young Song,Mee Sun Yoon,Sung-Ja Ahn,Woong-Ki Chung. (2022).PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy. 대한방사선종양학회지, 40 (1), 20-28

MLA

Ick Joon Cho,Jae-Uk Jeong,Taek-Keun Nam,Young-Eun Joo,Sung-Bum Cho,Yong-Hyub Kim,Ju-Young Song,Mee Sun Yoon,Sung-Ja Ahn,Woong-Ki Chung. "PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy." 대한방사선종양학회지, 40.1(2022): 20-28

결제완료
e캐시 원 결제 계속 하시겠습니까?
교보 e캐시 간편 결제